在活检证实的代谢功能障碍相关脂肪性肝病队列中定量超声参数测量肝脂肪变性的前瞻性对比诊断性能
该前瞻性研究纳入66例经组织病理学确诊的MASLD患者和34名年龄/性别匹配的健康志愿者,比较ATI、SWE和SWD检测及分级肝脂肪变性的诊断性能。ATI对≥S1、≥S2和=S3的AUC分别为0.917、0.933和0.870,均优于SWD;作者结论认为ATI是较SWE和SWD更可靠的检测和分级肝脂肪变性的方法。
要点
- ATI检测≥S1的AUC为0.917,cut-off为0.69 dB/cm/MHz。
- ATI检测≥S2的AUC为0.933,cut-off为0.74 dB/cm/MHz。
- ATI检测=S3的AUC为0.870,cut-off为0.82 dB/cm/MHz。
核心结论
- 作者结论认为ATI技术是较SWE和SWD更可靠的检测和分级MASLD患者肝脂肪变性的方法。
研究设计与样本
- 前瞻性研究纳入66例经组织病理学确诊的MASLD患者和34名年龄/性别匹配的健康志愿者,行ATI、SWE和SWD检查,以组织病理学确认的纤维化分期、坏死性炎症活动度和脂肪变分级为参考标准。
关键影像表现/征象
- 衰减系数(AC)和SWD值在不同肝脂肪变分级间均有显著差异,且均与肝脂肪变相关。
- ATI在检测和分级肝脂肪变性方面的诊断性能优于SWD。
诊断标准与关键数值
- 脂肪变分级标准:S0(<5%);S1(5%-32%);S2(33%-66%)至S3(>66%)。
- ATI检测≥S1的AUC为0.917,cut-off值为0.69 dB/cm/MHz。
- ATI检测≥S2的AUC为0.933,cut-off值为0.74 dB/cm/MHz。
- ATI检测=S3的AUC为0.870,cut-off值为0.82 dB/cm/MHz。
- SWD检测≥S1、≥S2和=S3的AUC分别为0.758(cut-off 10.79 m/s/kHz)、0.685(cut-off 12.64 m/s/kHz)和0.722(cut-off 13.24 m/s/kHz)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this study was to compare the diagnostic performance of attenuation imaging (ATI), shear wave elastography (SWE), and shear wave dispersion (SWD) for detecting and grading hepatic steatosis in patients with metabolic dysfunction associated steatotic liver disease (MASLD).
METHODS: Sixty-six patients with MASLD confirmed histopathologically and 34 healthy volunteers who were age/sex-matched were prospectively enrolled in this study. ATI, SWE, and SWD examinations were performed. Fibrosis stage, necroinflammatory activity, and steatosis grade were confirmed histopathologically. Steatosis was graded as follows: S0 (<5%); S1 (5%-32%); S2 (33%-66%) to S3 (>66%). We compared the diagnostic performance of ATI, SWE, and SWD for detecting and grading hepatic steatosis.
RESULTS: Both attenuation coefficient (AC) and SWD values were significantly different among the different hepatic steatosis, and both were correlated with hepatic steatosis. ATI had better diagnostic performance than SWD for detecting and grading hepatic steatosis. The area under the receiver operating characteristic (ROC) curve of ATI for detecting ≥S1, ≥S2, and =S3 were 0.917 (cut-off value of 0.69 dB/cm/MHz), 0.933 (cut-off value of 0.74 dB/cm/MHz), and 0.870 (cut-off value of 0.82 dB/cm/MHz), respectively. The area under the ROC curve of SWD value was 0.758 (cut-off value of 10.79 m/s/kHz), 0.685 (cut-off value of 12.64 m/s/kHz), and 0.722 (cut-off value of 13.24 m/s/kHz), respectively.
CONCLUSIONS: ATI technology is a reliable method for detecting and grading hepatic steatosis in patients with MASLD than SWE and SWD.
ADVANCES IN KNOWLEDGE: We compared the diagnostic performance of ATI, SWE, SWD for detecting and grading hepatic steatosis in patients with MASLD in order to find the best diagnostic parameters.
引用
- Wang K, Bao J, Wang M, et al. Prospective comparative diagnostic performance of quantitative ultrasound parameters for the measurement of hepatic steatosis in a biopsy-proven metabolic dysfunction associated steatotic liver disease cohort. Br J Radiol. 2025. PMID: 39436988. doi:10.1093/bjr/tqae212
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。